These successful investors, innovators and executives will share insights on identifying, funding and advancing new therapies that will transform the treatment of respiratory diseases.

Linda Armstrong

Linda Armstrong, MD

Global Head Respiratory Development Unit
Tara Butler

Tara Butler, MD

Managing Director
Ascension Ventures
Jason Chien

Jason Chien, MD

Senior Director, Clinical Research: Inflammation & Respiratory Division
Gilead Sciences
Badrul Chowdhury

Badrul Chowdhury, MD, PhD

SVP & Head of the Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit
MedImmune (AstraZeneca)
Anthony Flores

Anthony Flores

Managing Director, Head of Southwest Life Sciences & Healthcare
Silicon Valley Bank
Glenn French

Glen French

Pulmonx Corporation
Bill Gerhart

Bill Gerhart

Chairman & CEO
Patara Pharma
Cecelia Gonzalo

Cecilia Gonzalo

Oberland Capital
Gregory Grunberg

Gregory Grunberg, MD

Managing Director
Longitude Capital

Charles Hamilton

Principal, Investment Banking Healthcare
Piper Jaffray

Chau Khuong

Private Equity Partner
Kevin Kinsella

Kevin Kinsella

Founding Partner
Avalon Ventures
Ben Kramer

Benjamin Kramer, MD

VP, Immunology & Ophthalmology, US Medical Affairs

Onaiza Cadoret Manier

VP, Respiratory Franchise
Matthew McMahon

Matthew McMahon, PhD

Director, Office of Translational Alliances & Coordination
National Heart, Lung & Blood Institute, NIH
Marc Moss

Marc Moss, MD

American Thoracic Society
Ted Omachi

Ted Omachi, MD

Medical Director
Irina Petrache

Irina Petrache, MD

Chief & Professor, Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Colin Reisner

Colin Reisner, MD

CEO/Head, Respiratory Global Medicines
Pearl Therapeutics/AstraZeneca
Theodore Reiss

Theodore Reiss, MD, MBE

Corporate VP, Head of I&I Clinical R&D
Celgene Corporation
James Rosen

James Rosen

Managing Partner
Three Lakes Partners
Tom Salemi

Tom Salemi

Content Director

Sally Seymour, MD

Division Director (Acting) Division of Pulmonary, Allergy, & Rheumatology Products Center for Drug Evaluation & Research
US Food & Drug Administration (FDA)
Mahendra Shah

Mahendra Shah, PhD

Managing Director
Vivo Capital
Fred Van Goor

Fred Van Goor, PhD

Principal Research Fellow
Vertex Pharmaceuticals
Dennis Wahr

Dennis Wahr, MD

President & CEO
Tim Watkins

Timothy Watkins, MD

Director of Clinical Research, Respiratory & Inflammation Therapeutics
Gilead Sciences

James Willett

EVP, Chief Product & Innovation Officer